Interaction of PD-1 with its ligand, programmed death-ligand 1 (PD-L1) expressed by tumor cells, dampens anti-tumor T-cell responses through inducing T-cell apoptosis and attenuating T-cell receptor signaling thus impeding effector T-cell responses [25,26,27]. Here, CD274 is linked to neoplasm.